Truist raised the firm’s price target on Renasant to $38 from $32 and keeps a Hold rating on the shares as part of a broader research note recapping Q2 results in Community/Regional banks. The firm’s revisions primarily reflect lower fees offset partially by lower expenses related to the insurance agency sale that closes in Q3, the analyst tells investors in a research note. Expense control remains a positive, and Truist is forecasting growth of 2.4% and 3.3% in 2024/2025, the firm added.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RNST:
- Renasant Warns Investors of Forward-Looking Statements Risks
- Renasant reports Q2 EPS 69c, consensus 66c
- RNST Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Renasant Announces 2024 Second Quarter Webcast and Conference Call Information
- Renasant price target lowered to $32 from $33 at Truist